{
    "clinical_study": {
        "@rank": "60221", 
        "arm_group": {
            "arm_group_label": "hylauronin binding assay", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "We would like to determine if HBA\u00ae testing of sperm in couples with presumed idiopathic\n      infertility will reveal lower binding percentages than in couples with an identifiable cause\n      of infertility either male factor or tubal factor We would like to determine if patients\n      with abnormal HBA binding have decreased IVF outcome: decreases clinical pregnancy rate,\n      implantation rate, and increased miscarriage rate"
        }, 
        "brief_title": "The Value of HBA in the Evaluation of Idiopathic Infertility", 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  . All groups will include females under 40 years of age undergoing 1st IVF cycle 3\n             groups\n\n               1. Abnormal Semen Analysis (sperm count <10 million/ml and /or rapid progressive\n                  motility < 50 %, WHO morphology <30%)  normal HSG , normal ovarian reserve\n                  testing and ovulation testing\n\n               2. Unexplained infertility- normal ovarian reserve testing and ovulation testing\n                  (FSH< 10, AMH>1.0) Normal ovulatory cycles, normal WHO semen analysis. Normal\n                  tubes on HSG or Laparoscopy\n\n               3. Tubal infertility as assessed by HSG or laparoscopy\n\n        Exclusion Criteria:\n\n          -  women over 40, prior failed IVF"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01683435", 
            "org_study_id": "IRB 11-134"
        }, 
        "intervention": {
            "arm_group_label": "hylauronin binding assay", 
            "description": "HBA binding assay will be preformed on the discarded portion of semen analysis used for IVF.", 
            "intervention_name": "HBA binding assay", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "August 1, 2013", 
        "location": {
            "contact": {
                "email": "msauerbrun@chpnet.org", 
                "last_name": "May-Tal Sauerbrun", 
                "phone": "508-212-9076"
            }, 
            "contact_backup": {
                "email": "mdkeltz@aol.com", 
                "last_name": "Martin keltz", 
                "phone": "212 523 7751"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10019"
                }, 
                "name": "The Continuum Reproductive Center"
            }, 
            "investigator": {
                "last_name": "Martin Keltz", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Value of Hyaluronic Binding Assays (HBA) in the Evaluation of Idiopathic Infertility", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "In each of these groups we will assess presence of HBA bound sperm", 
            "safety_issue": "No", 
            "time_frame": "immediate at time of preforming HBA test"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01683435"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "St. Luke's-Roosevelt Hospital Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Luke's-Roosevelt Hospital Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}